logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

MNKD
MannKind Corporation
3.29
2 x 2.93
2 x 5.03
bid
ask
-
0.13
3.80%
2 @ 06:23 PM
3.32 +0.03 (0.91%)
Ytd-41.98%
1y-35.99%
3.23
day range
3.40
2.28
52 week range
6.21
Open3.40Prev Close3.42Low3.23High3.40Mkt Cap1.06B
Vol4.55MAvg Vol4.50MEPS-0.14P/EN/AForward P/E25.80
Beta1.08Short Ratio9.19Inst. Own57.04%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg3.83200-d Avg3.931yr Est7.84

MNKD News

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
globenewswire.com
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient

New analyses on Furoscix ReadyFlow PK/PD performance delivered via an autoinjector demonstrated comp

benzinga.com
Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

Truist Securities analyst Gregory Renza maintains MannKind (NASDAQ:MNKD) with a Buy and lowers th

benzinga.com
Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates MannKind (NASDAQ:MNKD) with a Overwei